Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online October 4, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0475v1
26/1/35    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deb, A.
Right arrow Articles by Dzau, V. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deb, A.
Right arrow Articles by Dzau, V. J
Submitted on June 19, 2007
Accepted on September 28, 2007

EMBRYONIC STEM CELLS

SFRP2 regulates cardiomyogenic differentiation by inhibiting a positive transcriptional auto-feedback loop of Wnt3a

Arjun Deb 1*, Bryce H Davis 1, Jian Guo 1, Aiguo Ni 1, Jing Huang 1, Zhiping Zhang 1, Hui Mu 1, Victor J Dzau 1

1 Division of Cardiovascular Diseases and Mandel Center for Hypertension Atherosclerosis Research, Department of Medicine, GSRB 2, Box 3178, Duke University Medical Center, Durham, NC 27710, PH: 919 668 5448, FAX: 919 684 4801

* To whom correspondence should be addressed. E-mail: arjun.deb{at}duke.edu.


   Abstract

Wnts comprise a family of 20 lipid modified glycoproteins in mammals and play critical roles during embryological development and organogenesis of several organ systems including the heart. They are required for mesoderm formation and have been implicated in promoting cardiomyogenic differentiation of mammalian embryonic stem cells, but the underlying mechanisms regulating Wnt signaling during cardiomyogenesis remain poorly understood. In this report, we show that in a pluripotent mouse embryonal carcinoma stem cell line, SFRP2 inhibits cardiomyogenic differentiation by regulating Wnt3a transcription. SFRP2 inhibited early stages of cardiomyogenesis, preventing mesoderm specification and maintaining the cells in the undifferentiated state. Using a gain and loss of function approach, we demonstrate that while addition of recombinant SFRP2 decreased Wnt3a transcription and cardiomyogenic differentiation, silencing of Sfrp2 led to enhanced Wnt3a transcription, mesoderm formation and increased cardiomyogenesis. We show that the inhibitory effects of SFRP2 on Wnt transcription are secondary to interruption of a positive feedback effect of Wnt3a on its own transcription. Wnt3a increased its own transcription via the canonical pathway and TCF4 family of transcription factors, and the inhibitory effects of SFRP2 on Wnt3a transcription were associated with disruption of downstream canonical Wnt signaling. The inhibitory effects of Sfrp2 on Wnt3a expression identify Sfrp2 as a "checkpoint gene", which exerts its control on cardiomyogenesis through regulation of Wnt3a transcription.

Key Words. myogenesis, P19, Wnt3a, teratocarcinoma




This article has been cited by other articles:


Home page
Circ. Res.Home page
M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
Circ. Res., November 21, 2008; 103(11): 1204 - 1219.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
Email Content Delivery
Copyright © 2007 by AlphaMed Press.